Ontario doctors advise Premier Ford to increase restrictions in new COVID framework
TORONTO, Nov. 12, 2020 /CNW/ - Ontario's doctors say the new framework for when regions can tighten and loosen pandemic restrictions is insufficient at a time when the province is reporting record numbers of COVID cases and called on Premier Doug Ford to fix it.
Doctors working on the front lines of the pandemic support the idea of a framework but say this one is too lax and allows too many businesses to remain open even when many people in their communities have the virus.
"Doctors are worried. It is clear the new tiered framework is not enough to control the virus, which is spreading among more and more people," said Dr. Samantha Hill, president of the Ontario Medical Association. "We must do more to protect the people of Ontario, especially those weaker than ourselves. That is why we are advising our partners in care, Premier Ford and Ontario mayors, to fix this framework and put more resources into testing and contact tracing in the meantime. You have the support of doctors to do it."
The new framework places each of Ontario's public health units in a green, yellow, orange, red or lockdown category based on a series of trends such as how many people are testing positive or being hospitalized.
Ontario's doctors recommend those trends, or thresholds at which regions move from tier to tier, should be much lower, in some cases 50 percent lower. We strongly recommend locations in the "restrict" (yellow) and "control' (red) categories should close bars and indoor dining altogether.
And for hotspots such as Toronto, Peel and Ottawa, which are all close to lockdown, Ontario's doctors strongly recommend stopping all non-essential services including all public events to gain control of the spread while strengthening public health measures.
We also applaud the local medical officers of health in Toronto and Peel Region for doing the right thing and increasing local measures beyond what the framework requires.
"Ontario's doctors want to work with Premier Ford to make our province as safe as possible for as many people as possible," said OMA CEO Allan O'Dette. "We can't have a healthy economy without healthy people. Following the recommendations of Ontario's doctors will stop the spread and support a safe reopening."
About the OMA
The Ontario Medical Association represents Ontario's 43,000-plus physicians, medical students and retired physicians, advocating for and supporting doctors while strengthening the leadership role of doctors in caring for patients. Our vision is to be the trusted voice in transforming Ontario's health-care system.
SOURCE Ontario Medical Association
Baxter Canada Announces First Regulatory Approval of New Novum IQ Infusion Platform
Pioneering platform offers both large volume and syringe infusion pumps, is foundational for continued innovation in medication delivery and management
Integrates Baxter's decades of leadership in infusion therapy with advanced digital health solutions, including the Dose IQ Safety Software—a web-based drug library software—and the IQ Enterprise Connectivity Suite, to build on the company's proven technology for protecting infusions from medication error
Offers both English and French language options to meet the needs of healthcare professionals across Canada
Health Canada approval represents first regulatory clearance in a series of planned submissions globally
MISSISSAUGA, ON, Nov. 12, 2020 /CNW/ - Baxter Canada, a leader in innovative technology for medication delivery, today announced Health Canada marketing authorization of its new Novum IQ Infusion Platform. Building on the company's decades of experience at the patient bedside, Novum IQ is the foundation for Baxter's continued innovation in medication delivery and management. The marketing authorization in Canada includes Novum IQ large volume (LVP) and syringe infusion pumps as well as the company's Dose IQ Safety Software, representing Baxter's latest developments for infusion therapy and medication safety. Novum IQ is expected to be available to Canadian customers in the coming weeks.
"We are excited to introduce Novum IQ, our newest infusion pump platform designed to provide personalized therapy and help prevent harm to patients." said Anne-Marie Carli, head of Baxter's Medication Delivery business in Canada. "The integrated platform provides for both large volumetric and syringe infusion pumps adding another option for Canadian hospitals to provide high-quality infusion therapy for patients. Novum IQ is a full-suite package offered in both English and French."
Protecting More Infusions with Advanced Technologies
Advancing the safety and efficiency of medication delivery and management is critical, as data continues to show the harmful burden of errors on patient safety.1,2 In addition to offering both LVP and syringe infusion pumps, Novum IQ utilizes intuitive technologies built to protect infusions.
Novum IQ features Baxter's Dose IQ Safety Software, a web-based, customizable drug library and dose error reduction system. A well-managed drug library is a key safety feature of smart infusion pumps to assist clinicians in reducing the occurrence of potential dosing errors. Dose IQ helps hospitals by:
Helping ensure pumps are up-to-date with the latest dose information through centralized access to drug library files
Working across LVP and syringe pumps with the ability to differentiate enteral delivery on the syringe pump through designated screen colors
Novum IQ fully integrates with hospital electronic medical records (EMRs) through Baxter's IQ Enterprise Connectivity Suite – a software which also:
Enables over-the-air drug library and software updates to all Novum IQ pumps connected to a hospital's network
Provides clear visualizations of infusion data across a hospital system, allowing efficient identification of safety and process issues at every level of care
Based on clinical setting and patient need, hospitals benefit from having access to both LVP and syringe pumps. As LVPs deliver fluid from intravenous (IV) bags and syringe pumps from a syringe, LVPs typically administer higher volumes of fluid at faster rates. Syringe pumps are often used to precisely deliver small amounts of fluid at low rates, often in pediatric, neonatal or anesthesia care settings. The Novum IQ Infusion Platform integrates user experience across its LVP and syringe pumps, with shared safety features, advanced connectivity and a consistent, intuitive interface.
About Baxter Canada
Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. In Canada, we've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen for 83 years. With products, technologies and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. Baxter Canada and its over 1,200 employees are located primarily in Ontario at the Head Office, CIVA Admixing and Technical Services Centres in Mississauga, and in Alliston – where Baxter operates Canada's only large-scale manufacturing plant producing life-sustaining intravenous and dialysis solutions. To learn more, visit www.baxter.ca and follow Baxter on LinkedIn
For safe and proper use of this device, refer to the Operator Manual.
Indications for Use:
Novum IQ Large Volume Pump
The Novum IQ LVP is intended to be used for the controlled administration of fluids. These include parenteral pharmaceutical drugs, nutrition, blood and blood products.
The Novum IQ LVP is intended to deliver an infusion through clinically acceptable routes of administration: intravenous, arterial, subcutaneous, and epidural.
The Novum IQ LVP is intended to be used in conjunction with legally marketed and compatible intravenous administration sets, and medications provided by the user.
The Novum IQ LVP is suitable for patient care in hospitals and outpatient health care facilities.
The Novum IQ LVP is intended for use on adults, pediatrics and neonates.
The Novum IQ LVP is intended to aid in the reduction of operator interaction through guided programming, including a way to automate the programming of infusion parameters and documentation of infusion therapies. This automation is intended to aid in the reduction of programming errors.
The Novum IQ LVP is intended to be used by trained healthcare professionals.
Novum IQ Syringe Pump:
The Novum IQ Syringe Infusion Pump is intended to be used for the controlled administration of fluids. These include parenteral pharmaceutical drugs, nutrition, blood and blood products, and enteral nutrition.
The Novum IQ Syringe Infusion Pump is intended to deliver an infusion through clinically accepted routes of administration: intravenous, arterial, enteral, and subcutaneous.
The Novum IQ Syringe Infusion Pump is intended to be used in conjunction with legally marketed and compatible administration sets, syringes, and medications provided by the user.
The Novum IQ Syringe Infusion Pump is suitable for patient care in hospitals and outpatient health care facilities.
The Novum IQ Syringe Infusion Pump is intended for use on adults, pediatrics and neonates.
The Novum IQ Syringe Infusion Pump is intended to aid in the reduction of operator interaction through guided programming, including a way to automate the programming of infusion parameters and documentation of infusion therapies. This automation is intended to aid in the reduction of programming errors.
The Novum IQ Syringe Infusion Pump is intended to be used by trained healthcare professionals.
Baxter, Novum IQ, Dose IQ and IQ Enterprise are registered trademarks of Baxter International Inc.
St. Joseph's Health System, Niagara Health launch new innovative care model COVID Care @ Home
HAMILTON, ON, Nov. 12, 2020 /CNW/ - COVID Care @ Home is a new model of care delivered by St. Joseph's Home Care (SJHC), in partnership with St. Joseph's Health System (SJHS), Niagara Health and community partners that connects patients to care wherever they are, whenever they need it.
Starting at St. Joseph's Healthcare Hamilton and Niagara Health, with rapid expansion to Kitchener, this new model of care for COVID patients will provide 24/7 access to high-quality care from one integrated team in the home and in community settings like retirement homes, shelters and hospices.
COVID Care @ Home is a uniquely designed program intended for those with a confirmed COVID diagnosis who do not require hospitalization. Complimenting existing local COVID initiatives, the program will support integrated care at home, early discharge from hospitals with supports and help to prevent hospitalization. It will also help to prevent outbreaks by providing Infection Prevention and Control (IPAC) and coaching support for community congregate settings.
Patients will be assessed to determine what level of service will be provided. Vulnerable patients who are at risk of hospitalization and who require additional supports and services will have access to an integrated clinical care team, remote monitoring and at-home and virtual visits to support a safe recovery at home. This same model of care will be available to patients discharged from hospital so they can safely return home sooner.
This innovative, flexible model would provide COVID patients access to services that may not typically be within the scope of traditional home and community care supports. Patients will be cared for by one integrated team representing a variety of providers whose clinical decisions are empowered through the use of a single electronic patient record to support patients in the following ways:
Virtual Care (phone, video and remote patient monitoring)
One number to call 24/7
One clinical team
One electronic record
System navigation / connection to social supports
Access to specialists
IPAC Support
St. Joseph's Home Care will lead this innovative transformation to connect home care to a broad range of services for COVID patients and work in collaboration with other service provider organizations and primary care.
SJHS is one of the largest healthcare organizations in Canada, and the only system in Ontario delivering a full continuum of integrated health care services.
"We've learned a tremendous amount about COVID-19 over the last several months," said Tom Stewart, St. Joseph's Health System President and CEO and CEO of Niagara Health. "This new program builds on partnerships and learnings by increasing our focus on virtual care and specialized COVID care teams that crosses normal silos of care. This will help us through the second and future waves of the pandemic as well as prepare us for system transformation needed in healthcare."
The program is designed to support older adults who are at greater risk of physical and mental health decline. Patients will be enrolled by the clinical teams at the time of their COVID 19 diagnosis.
The new model will also help to protect capacity in hospitals by expanding supports and services in the community through a dedicated team that will facilitate care at home, support safe discharges from hospital and limit unnecessary Emergency Department visits. This will help hospitals to maintain capacity and services during a second wave as well as continuing scheduled surgeries to reduce wait lists and backlogs.
Since 1921, St. Joseph's Home Care has provided high quality, values-based home and community services in a spirit of compassion and dedication. We have evolved from a nursing agency to offering a much broader range of services, and our steadfast commitment to delivering exemplary client-focused care to the Hamilton community continues.
About St. Joseph's Health System
St. Joseph's Health System (SJHS) is one of the largest healthcare organizations in Canada, and is the only system in Ontario delivering a full continuum of health care services. SJHS is a globally recognized leader for innovation in models of patient-centred integrated care. SJHS has a unique partnership with Niagara Health to leverage each organization's strengths to bring better care to the people in the communities we serve.
About Niagara Health:
Niagara Health is a regional healthcare provider with multiple sites and a growing network of virtual and community-based services. We provide a wide range of inpatient and outpatient services to more than 450,000 residents across Niagara, including Acute Care, Cancer Care, Cardiac Care, Complex Care, Emergency and Urgent Care, Kidney Care, Long-Term Care, Mental Health and Addictions, Stroke Care and Surgical Care.
About St. Joseph's Healthcare Hamilton
As a premier academic and research healthcare organization, St. Joseph's Healthcare Hamilton is committed to making a difference in people's lives and creating a lasting future for our community through integrated health services and internationally recognized programs. Our threefold mission is to provide dynamic research, revolutionary methods in health sciences education and the highest standard of clinical care in a spirit of compassion, innovation and commitment.
SOURCE St. Joseph's Health System
NBC Public Health Analyst: Invest in Our Children Now for the Sake of Our Country’s Future
New York, NY, November 12, 2020 — NBC public health analyst, pediatrician and activist Dr. Irwin Redlener has a powerful message for all of us: too many American children face insurmountable obstacles that keep them from achieving their dreams, and this “reflects a moral failure” and threatens our country’s economic viability and international influence going forward.
"I think of the children who dream big, who aspire to the same life goals as my own grandchildren, and who deserve to have the pathways and possibilities for their lives wide open,” writes Dr. Redlener in his poignant memoir and inspirational call to action, The Future of Us: What the Dreams of Children Mean for Twenty-First-Century America.
Inadequate education, barriers to health care and crushing poverty make it overwhelmingly difficult for many children to realize their dreams. Finding ways to alter these trajectories is serious, grown-up business, Dr. Redlener emphasizes, and it’s time for us to act.
In The Future of Us, Dr. Redlener draws upon his four decades of professional experiences to examine our nation’s health care safety nets and special programs that are designed to protect and nurture our most vulnerable kids, but that too often fail to do so.
The book follows Dr. Redlener’s long, colorful career, from his work as a pediatrician in the Arkansas delta, to treating child abuse in a Miami hospital, to helping children in the aftermaths of 9/11 and Hurricane Katrina. He has served on the board of USA for Africa, cofounded the Children’s Health Fund with Paul Simon (and persuaded Joan Baez to play a benefit concert) and dined with Fidel Castro. He once sat across the table from Michael Jackson, and he has traveled with presidential candidates. But his most powerful source of motivation remains the children who face terrible adversities yet dream of becoming paleontologists, artists and marine biologists. Their stories are his springboard for discussing larger policy issues that hinder us from effectively eradicating childhood poverty and overcoming barriers to accessible health care. Persistent deprivation and the avoidable problems that accompany poverty ensnare millions of children and impact the health, prosperity and creativity of the adults they become. Dr. Redlener argues that we must drastically change our approach to meeting the needs of children ― for their sake and to ensure America’s resiliency and influence in an increasingly complex world.
It is Dr. Redlener’s hope that readers will emerge optimistic about our future, with a deeper understanding of how investing in children today will increase our chances of a successful tomorrow. Fighting for our nation’s children is far from a lost cause, and nothing could be more important.
Author Irwin Redlener, M.D., is a pediatrician and founding director of the National Center for Disaster Preparedness at Columbia University’s Earth Institute, which works to understand and improve the nation's capacity to prepare for, respond to, and recover from disasters. In 2020, Dr. Redlener created the Pandemic Resource and Response Initiative at Columbia. He is a public health analyst for NBC and MSNBC, and recently partnered with Cher in CherCares, a new program that assists communities struggling with COVID-19.
Dr. Redlener is also President Emeritus and Co-Founder of the Children’s Health Fund, a philanthropic initiative that he created with singer/songwriter Paul Simon and Karen Redlener to develop health care programs in 25 of the nation’s most medically underserved urban and rural communities. He currently serves as a special advisor on emergency preparedness to New York Mayor Bill de Blasio, and regularly communicates with leadership in U.S. Departments of Health and Human Services, as well as Homeland Security.
He is also the author of Americans at Risk: Why We Are Not Prepared for Megadisasters and What We Can Do Now. For more information, please visit www.irwinredlener.org.
The Future of Us: What the Dreams of Children Mean for Twenty-First-Century America
DECN GENVIRO! TRIAL USING HUMAN SALIVA DONORS FOR ITS SWIFT TEST KITS PROCEEDS DIRECTLY TO FDA LEVEL TESTING AS COVID-19 PRODUCT TESTING ENTERS “HOME STRETCH”
____________________________
With Favorable testing Results anticipated on november 13 from our FDA and CLIA certified laboratory, decn estimates completion and filing of 3rd fda eua application in the next 3 weeks
LOS ANGELES, CA / ACCESSWIRE / November 12, 2020 / Decision Diagnostics Corp. (OTC: DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., today announced its donor study has entered its final stages, and that having yielded better and quicker than anticipated results a separate feasibility study will not be required. The company is now actively testing known positive and negative Covid-19 patients in an effort to finish its FDA EUA submission estimated to be filed in the next 3-4 weeks or as soon as the complex EUA application is completed. The company is currently reviewing drafts of this application. The donor study will provide exact data requirements for FDA EUA, EU CE Mark and Russian Federation applications for the Genviro! Saliva Swift Kit for the detection of Covid-19.
“Testing for Genviro! has been so encouraging that on Tuesday, November 10, 2020 our certified testing lab partner informed us that we can avoid doing two studies and instead move to direct patient testing of positive and negative Covid-19 human samples required for FDA submission. That’s taking place right now” said CEO Keith Berman. “As such, we have been informed that testing is in the “home stretch,” and we estimate an FDA submission in a brief period after receiving results from our testing partner with the results to be incorporated in our FDA EUA application.
Berman continued “The testing of positive and negative human saliva samples is demonstrating a number of critical findings. One such finding concerns the identification of sample results where we anticipate positive results to be just that, positive, and the identification of negative results to also be just that, negative. In marked contrast to the expected GenViro! Swift Kit result reporting, there are popular testing methods currently on the market that have what we consider largely unacceptable false negative rates. Numerous news articles have confirmed this. We have also commented on this. The FDA is paying particular attention to the incidence of false negative reporting.”
Berman further stated, “The current testing will also allow us to do the final programming of algorithms for the Genviro! Swift Kit meters, fixing the version level at version 1.7. We will also be enhancing our meters with the ability to provide a qualitative measure of certain probabilities. This additional meter feature, version 2.1, is expected to be implemented early in 2021. We will expand on that capability in subsequent announcements as more results become available and are validated. With all of this data available in approximately 10 seconds, at the actual point of care or testing, we believe now more than ever that we have what will turn out to be the most desirable technology available for rapid and reliable Covid detection.”
DECN had previously targeted the fourth quarter, 2020 for FDA EUA, EU CE Mark and Russian Federation submissions. We do not anticipate any deviation from this schedule, at least as far as the application from the Russian Federation is concerned. As was highlighted in a prior announcement, the company is emboldened about the efficacy of its saliva technology because of recent media and academic reports showing that saliva may well be the best way to detect the presence of Covid-19 in a virtually non-invasive method.
ABOUT DECISION DIAGNOSTICS CORP
Decision Diagnostics Corp. is the leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters. DECN's products are designed to operate efficiently and less expensively on certain glucose meters already in use by almost 7.5 million diabetics worldwide. With newly inspired technology, and diabetic test strips already in the final stages of development, DECN products compete on a worldwide scale with legacy manufacturers currently selling to 71+ percent of a $15+ billion at-home testing market.
The company's new GenViro!™ products designed to test for Covid-19 are not yet available in the United States or Puerto Rico, but Emergency (EUA) Waivers are in process with the U.S. FDA with additional submissions to take place in the near future. The company has also signed an agreement with an FDA and CLIA certified US, Pennsylvania-based testing partner to complete testing per current FDA guidelines and continues to look forward to the FDA authorization of its EUAs.
The same data that will be produced by the company’s Pennsylvania testing partner will be used for submissions to the EU and Russian Federation. We will also use data provided by our Korean R&D and contract manufacturing partner as part of their extensive product development schedule and as part of the XPRIZE initiative which is progressing as yet a third validation of the testing methodology.
Beyond the testing, the company has received word from several of its large GenUltimate distributors who are seeking to have Genviro! added to their Amazon product offerings upon FDA approval. Currently, Amazon only offers special licenses for point of care and professional use medical products, which would preclude the individual use GenViro! Kit from being available on Amazon, even after FDA approval is secured. Two of the company’s GenUltimate product distributors have these “professional use” arrangements with Amazon, with a third distributor application in the works, although the company may determine that it is in its best interest to offer limited exclusivity to one distributor once FDA authorization is achieved.The company continues to recruit and accept applications from prospective domestic and international distributors. Inquiries can be directed to info@decisiondiagnostics.co.
Forward-Looking Statements:
This release contains the company's forward-looking statements which are based on management's current expectations and assumptions as of November 10, 2020, regarding the company's business and performance, its prospects, current factors, the economy, and other future conditions and forecasts of future events, circumstances, and results.
COVID-19 Continues to Cause Grief, High Stress and Spending Woes in Young Adults
Atlanta, GA, November 12, 2020 — We have a new norm in the United States: the majority of young adults between the ages of 18 to 34 — about 26.6 million — now live at home with their parents, according to a recent survey by the Pew Research Center.
Supporting grown children can be stressful, especially if your income has been impacted by the pandemic, but there are ways to take control of your family’s finances and map a path toward financial independence for your young adult.
Nicola Smith Jackson, bestselling author, financial advisor and TV analyst confirms, “Undergraduates at unprecedented levels are forced to make drastic changes, moving back home and studying remotely. Many are also forced to take a gap year because of the times. College graduates are also facing the worst job market, and student debt is at an all-time high — also putting a severe strain on their finances. More than seven in 10 graduates are in the red, owing more than $30,000 in student loans, and those already in the workforce are more likely to lose their jobs or take a severe pay cut.”
Even before the pandemic, young adults were increasingly dependent on their parents. About six in 10 parents with children between the ages of 18 and 29 said they have given their kids at least some financial help in the past year — primarily for recurring expenses such as tuition, rent, groceries or bills, Pew reported.
“Supporting grown children adds additional stress to parents when their own financial security is at risk, from medical coverage to auto insurance, groceries and internet, there are hidden costs to having children come back home, and it doesn’t look like it will be getting better any time soon,” says Jackson.
One thing families can do: use this together-time as an opportunity to teach your millennials about finances, and when you do, Jackson advises covering the following topics to help your young earner become more stable:
Avoid bad debt
Save to invest
Borrow only what you need
Generate passive income
Budget, budget, budget
Dr. Nicola Jackson has over 25 years of entrepreneurial experience. She currently leads a multimillion-dollar team of agents consisting of tens of thousands in the financial service industry. She has also led over 450,000 sales representatives in more than 30 countries. As a wife and mother of four, including one child disabled, she turned her pains into passion after burying three children by the age of 23. She holds true to her Christian faith and uses Kingdom values and principles to deliver a sound message to thousands of people around the nation on how to manage a household, maintain a strong marriage and create a multimillion-dollar empire. Dr. Jackson was also an Executive Producer and star on the BET Centric hit reality series, Amateur Millionaires Club; has been featured in several national publications; and is a highly sought after speaker. She has shared the stage with the likes of Dr. Myles Munroe, Dr. Maya Angelou, Ambassador Andrew Young, Bishop Paul Morton, Steve Harvey, Tommy Dortch, Magic Johnson, Dr. Bernice King and many other world-renowned speakers. She is the host of the popular radio show and podcast, “Power Start Your Day.” She is also the author of Inside the Millionaire’s Vault and her upcoming books, Power Moves Journal for the Unstoppable Entrepreneur and Cash The Check, Time-tested Wealth Principles You Can Take to the Bank.
She founded the Pink Millionaire Club where she mentors women on how to “Connect the dots between the haves and the have nots” through Prayer, Impact, Nurturing and Knowledge. Currently, Dr. Jackson travels the world speaking to thousands on the topics, “Live and Die Rich” and “How to Become a Successful Entrepreneur While Being Spiritually Grounded.” She has dedicated her life to empowering others with opportunities and financial literacy to build wealth and legacies for families around the globe.
###
The Best Beauty + Wellness Black Friday/Cyber Monday Deals from Amazon + More! The biggest shopping holiday of the season starts soon and whether you are treating yourself or getting a jump on your holiday shopping, check out these beauty deals from Amazon exclusive K-beauty brands Donginbi, Enough Project, Madeca Derma or buy from straight from the source for LAPCOS, Nourishe Organics, Chakra Balms and more!
Chakra BalmsTerms: Receive the Chakra Balm full set for $99 (originally $111)Date: Nov 23 - Nov 30Website: www.chakrabalms.com
Nourishe OrganicsBlack Friday Sale:Date: 11.26 - 11.27Promotion: Buy 4 or more products and receive 10% off Small Business Saturday:Date: 11.28Promotion: 25% off Essential Line Products, 40% off Luxury Line Products, plus free shipping + gift with purchaseCyber Monday:Date: 11.28 - 11.30Promotion: BOGO on select products plus 60% off Roseia productsWebsite: https://www.amazon.com/nourisheorganics
Undo Overeating and Halt Weight Gain with this Breakthrough, Science-Backed Program
San Francisco, CA, November 12, 2020 — The premise of Whole Person Integrative Eating: A Breakthrough Dietary Lifestyleto Treat the Root Causes of Overeating, Overweight, and Obesity is simple yet powerful: Identify the reasons you overeat (your overeating styles) and gain weight—with the illuminating self-assessment quiz—then overcome overeating and lose weight by replacing your overeating styles with the antidotes: the elements of the Whole Person Integrative Eating program.
By shedding light on the root causes of overeating, holistic nutrition researcher Deborah Kesten, M.P.H., and behavioral scientist Larry Scherwitz, Ph.D., present a program that empowers readers with a personalized plan, and in turn new hope and new choices to help them reduce overeating, lose weight, and keep it off. “The combined effect of all seven ‘ingredients’ of Whole Person Integrative Eating makes the transformative difference,” says Kesten.
Plus, you’ll discover 65 delicious recipes based on the Whole Person Integrative Eating (WPIE) program to jumpstart your optimal-eating efforts.
WPIE is not a diet that a person goes on … then off. It is a scientifically sound, dietary lifestyle designed to be practiced for a lifetime.
"If people follow the revolutionary program outlined in this game-changing, insightful book, it may be the most helpful step they can take toward losing weight and keeping it off," says bestselling author Kenneth Pelletier, M.D., clinical professor of medicine at University of California School of Medicine, San Francisco.
An excerpt from the Foreword of Whole Person Integrative Eating by New York Times best-selling author Dean Ornish, M.D., Clinical Professor of Medicine, University of California:
“The takeaway message in this well-researched and illuminating book is this: the antidote to overeating, overweight, and obesity and perhaps other diet-related chronic conditions may be to follow the ancient-food-wisdom-based guidelines that Kesten and Scherwitz describe in this book.”
The authors’ paradigm-shifting message is that food influences not only the physical dimensions of health, but also our emotional, spiritual and social well-being. Their dietary lifestyle can build bridges between the millions who struggle with overeating and weight issues and the medical community. And it can inspire us all to re-envision our relationships with food, eating and weight, so that each time we eat, we are nourished … for life.
Deborah Kesten, M.P.H.,is an international nutrition researcher, award-winning author and medical/health writer, with a specialty in preventing and reversing obesity and heart disease. She served as Nutritionist on Dean Ornish, M.D.’s first clinical trial for reversing heart disease through lifestyle changes, the results of which were published in the Journal of the American Medical Association. She has served as Director of Nutrition at cardiovascular clinics in Europe and on the Board of Directors of the American Heart Association, San Francisco.
Kesten has published more than 400 nutrition and health articles. Her first book, Feeding the Body, Nourishing the Soul, received the first-place gold award in the Spirituality category from the Independent Publisher Book Awards. Whole Person Integrative Eating has been honored with the No.1 gold, best-book award in the Health category by Book Excellence Awards. She is a VIP Contributor at Arianna Huffington’s Thrive Global, and is married to behavioral scientist and co-author of Whole Person Integrative Eating, Larry Scherwitz, Ph.D.
Health Food Innovator Edward & Sons Trading Company, Inc. – First To Introduce Miso-Cup® Instant Soup & Gluten-Free Baked Brown Rice Snaps® To American Consumers –Marks 40th Anniversary Milestone
CARPINTERIA, CA., MARCH 8, 2018 - The first Whole Foods Market wouldn’t open in Austin, Texas, for another two years. The first Sprouts wouldn’t make its debut in Arizona for another 24 years. Vegetarians were relegated to the shadows in most supermarket settings, and for much of the population, the term Vegan sounded like something out of “Star Trek.”
The year was 1978 and the health food revolution was in its infancy. But a young man named Joel Dee with a vision of what the industry could one day become saw the future. And it was delicious.
As a young man, Joel worked alongside his two brothers and their father, Edward, in the family’s iconic New Jersey-based business, Smarties Candy Company. But, as fate would have it, Joel’s interests extended well beyond the confection industry.
“I was responsible for export sales at the candy company and found it difficult to maintain a healthy, satisfying diet while on-the-road,” Joel recalls today. “Health food stores sold wholesome foods that required a kitchen and a long cooking time, both in short supply to a `road warrior’ such as myself. Conventional supermarkets sold convenience foods that were laced with preservatives and artificial ingredients, which I was determined to avoid. To make things even tougher, I had recently become vegetarian, so my restaurant menu options were often limited to salad and potatoes... not exactly a balanced diet.”
Adds Joel, “I was a traveling salesman who needed portable, nourishing, easy to prepare vegetarian food without artificial ingredients, but I couldn’t find it anywhere in 1976 America. I wondered: Could I be the only person who wants this? I hadn’t planned to start a new business, but I felt somewhat obliged to. If I wouldn’t take on the job of creating wholesome, vegetarian convenience foods, it occurred to me that no one else would either.”
With that motivation in mind, Joel began a two year effort to develop Miso-Cup® instant soup mix and, with its launch in 1978, Edward & Sons Trading Company, Inc. was born.
A History of “Firsts”
As it turned out, introducing instant Miso-Cup soup would be only the first of numerous company innovations that would continue for the next forty years. In 1979, for example, Edward & Sons introduced Baked Brown Rice Snaps® whole grain, gluten free crackers, decades before American shoppers would demand gluten free groceries on a massive scale. Numerous “first-to-market” vegan organic products followed, including canned coconut milk, hearts of palm, pineapple chunks and mandarin oranges, Worcestershire sauce, croutons, panko, ice cream cones and many more.
According to Joel, “We tend to do `firsts’ because that’s what we’re passionate about. We are driven to provide new options to our health-aware consumers, while creating markets for our ethical organic farmers and packers around the globe. We’re proud of our activities that protect native forests and support conversion from conventional to organic farming, which nourishes the environment while enhancing the well-being of everyone along the supply chain from farm to table.”
Indeed, Joel and his team have successfully developed so many different products over these past 40 years that they’ve chosen to create subsidiary brands to market and distinguish them all, including the flagship Edward & Sons® brand as well as Native Forest®, Let’s Do Organic®, Let’s Do Gluten-Free®, More Than Fair®, Nature Factor®, Road’s End Organics®, Premier Japan® and The Wizard's®.
Regardless of the brand name on the package, however, all products under the Edward & Sons umbrella are defined by the company’s longstanding commitment to excellent vegetarian food and to its enduring motto: Convenience Without Compromise.®
As Joel sums up, “We remain a vegetarian company that’s mission-driven to offer consumers delicious and nourishing convenience foods free of artificial ingredients. That’s how we’ve run the business for the past 40 years and it’s how I envision Edward & Sons to be run for the next 40 years - and beyond.”
Success Stories Show that Low Dose Naltrexone Helps Many People with Autoimmune Diseases
Chicago, IL, November 11, 2020 — Lupus, rheumatoid arthritis, Crohn’s, psoriasis,fibromyalgia and other autoimmune conditions affect nearly 23.5 million Americans, according to the National Institutes of Health.
In her thought-provoking book, The Power of Honest Medicine, patient advocate JuliaSchopick (with Don Schwartz) outlines a safe, inexpensive, often dramatically effective alternative to the costly, often-toxic treatments that doctors routinely prescribe for autoimmune and other diseases. It’s called Low Dose Naltrexone (LDN), and The Power of Honest Medicine is filled with compelling success stories from people all over the globe who have experienced relief from their symptoms thanks to LDN.
“There is lots of evidence that LDN is a groundbreaking treatment for autoimmune diseases, helping many patients with these conditions to achieve remission,” Julia writes. “In some cases, it can slow or stop the progression of their diseases. In many cases, patients experience a life-changing relief of symptoms.”
In spite of its documented benefits, the use of LDN to treat autoimmune conditions remains largely unknown among the medical community and the public. Julia is committed to changing that.
The Power of Honest Medicine contains contributions from 18 people from around the world (the U.S., the U.K. and Europe), all of whom are eager to spread the word about how LDN helped alleviate their symptoms of serious conditions—such as chronic fatigue syndrome, Crohn’s, multiple sclerosis, Parkinson’s disease, rheumatoid arthritis, lupus and fibromyalgia—when the higher priced, often-toxic medications they had been taking didn’t work. Also, with many of these conditions, the drugs doctors prescribe can cost thousands of dollars a month, compared with LDN, which costs around a dollar a day.
Additionally, The Power of Honest Medicine contains a section dedicated to helping readers understand LDN and why it has the potential to positively impact those suffering from autoimmune disorders. Plus, the book includes a chapter with strategies for helping readers convince their doctors to prescribe LDN—information Julia has been asked for again and again by her readers and by those who have heard her speak.
Ever since her husband’s death from a brain tumor in 2005, Julia has dedicated her life to patient advocacy and to sharing information about potentially lifesaving alternative and off-label medical treatments. Her first book, Honest Medicine, offered valuable insights supported by patient testimonials regarding the use of four underutilized lifesaving treatments: Silverlon, for non-healing wounds; intravenous alpha lipoic acid, for liver disease; the Ketogenic Diet, for epilepsy; and Low Dose Naltrexone,for autoimmune diseases.
Julia’s husband survived 12 years beyond any doctor’s prognosis, and she attributes this to the innovative treatments she uncovered for him. It’s been her passion since then to prevent others from suffering unnecessarily and having to juggle the side effects of toxic medications with the debilitating symptoms of their health conditions.
“I believe that LDN would be the standard of care for autoimmune diseasesif Big Pharma didn’t rule doctors’ prescribing decisions,” she adds.
Julia Schopick is the bestselling author of Honest Medicine and her follow-up book, The Power of Honest Medicine. She is a seasoned radio talk show guest who has appearedon over 200 shows and is often invited back. Julia’s goal is to empower patients to make the best health choicesfor themselves and their loved ones by teaching them about little-known but promisingtreatments their doctors may not know about. Julia’s articles have been featured in numerous publications, including American Medical News (AMA), Alternative & Complementary Therapies, the British Medical Journal and the Chicago Sun-Times.
